Merck To Kick Off 2nd Round Of Fosamax Suits In NJ
Merck & Co. Inc. is set to face trial later this month in New Jersey over claims that its bone drug Fosamax causes femur fractures, as it attempts to replicate the...To view the full article, register now.
Already a subscriber? Click here to view full article